LU76367A1 - - Google Patents
Info
- Publication number
- LU76367A1 LU76367A1 LU76367A LU76367A LU76367A1 LU 76367 A1 LU76367 A1 LU 76367A1 LU 76367 A LU76367 A LU 76367A LU 76367 A LU76367 A LU 76367A LU 76367 A1 LU76367 A1 LU 76367A1
- Authority
- LU
- Luxembourg
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pyrrole Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19752556326 DE2556326A1 (de) | 1975-12-13 | 1975-12-13 | Neue pyrrolidone und verfahren zu ihrer herstellung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| LU76367A1 true LU76367A1 (xx) | 1977-06-28 |
Family
ID=5964379
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LU76367A LU76367A1 (xx) | 1975-12-13 | 1976-12-10 |
Country Status (13)
| Country | Link |
|---|---|
| JP (1) | JPS5273865A (xx) |
| AU (1) | AU2047376A (xx) |
| BE (1) | BE849346R (xx) |
| CA (1) | CA1072108A (xx) |
| DE (1) | DE2556326A1 (xx) |
| DK (1) | DK554776A (xx) |
| FR (1) | FR2334352A2 (xx) |
| GB (1) | GB1569982A (xx) |
| IL (1) | IL51090A0 (xx) |
| LU (1) | LU76367A1 (xx) |
| NL (1) | NL7613643A (xx) |
| SE (1) | SE7613948L (xx) |
| ZA (1) | ZA767379B (xx) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4772601A (en) * | 1988-01-25 | 1988-09-20 | Hoechst-Roussel Pharmaceuticals, Inc. | 5-Substituted 1-(4-(1-pyrrolidinyl)-2-butynyl)-2-pyrrolidinones, pharmaceutical compositions and use |
| RU2296122C2 (ru) | 2001-07-16 | 2007-03-27 | Ф.Хоффманн-Ля Рош Аг | Производные 2-пирролидона в качестве простаноидных агонистов и фармацевтическая композиция |
| ES2254726T3 (es) | 2001-07-16 | 2006-06-16 | F. Hoffmann-La Roche Ag | Analogos de prostaglandina como agonistas receptores de ep4. |
| NZ530885A (en) | 2001-07-23 | 2007-09-28 | Ono Pharmaceutical Co | Remedies for diseases with bone mass loss having EP4 agonist as the active ingredient |
| AU2003211574A1 (en) | 2002-03-05 | 2003-09-16 | Ono Pharmaceutical Co., Ltd. | 8-azaprostaglandin derivative compounds and drugs containing the compounds as the active ingredient |
| RU2311409C2 (ru) | 2003-01-10 | 2007-11-27 | Ф.Хоффманн-Ля Рош Аг | Производные 2-пиперидона в качестве агонистов простагландина |
| US7179820B2 (en) | 2003-06-06 | 2007-02-20 | Allergan, Inc. | Piperidinyl prostaglandin E analogs |
-
1975
- 1975-12-13 DE DE19752556326 patent/DE2556326A1/de active Pending
-
1976
- 1976-12-08 NL NL7613643A patent/NL7613643A/xx not_active Application Discontinuation
- 1976-12-10 ZA ZA767379A patent/ZA767379B/xx unknown
- 1976-12-10 LU LU76367A patent/LU76367A1/xx unknown
- 1976-12-10 SE SE7613948A patent/SE7613948L/xx unknown
- 1976-12-10 IL IL51090A patent/IL51090A0/xx unknown
- 1976-12-10 DK DK554776A patent/DK554776A/da unknown
- 1976-12-10 AU AU20473/76A patent/AU2047376A/en not_active Expired
- 1976-12-13 CA CA267,691A patent/CA1072108A/en not_active Expired
- 1976-12-13 JP JP51148823A patent/JPS5273865A/ja active Pending
- 1976-12-13 GB GB51912/76A patent/GB1569982A/en not_active Expired
- 1976-12-13 FR FR7637469A patent/FR2334352A2/fr active Granted
- 1976-12-13 BE BE173206A patent/BE849346R/xx active
Also Published As
| Publication number | Publication date |
|---|---|
| FR2334352B2 (xx) | 1978-12-08 |
| GB1569982A (en) | 1980-06-25 |
| JPS5273865A (en) | 1977-06-21 |
| IL51090A0 (en) | 1977-02-28 |
| BE849346R (fr) | 1977-06-13 |
| AU2047376A (en) | 1978-06-15 |
| SE7613948L (sv) | 1977-06-14 |
| DE2556326A1 (de) | 1977-06-23 |
| CA1072108A (en) | 1980-02-19 |
| FR2334352A2 (fr) | 1977-07-08 |
| DK554776A (da) | 1977-06-14 |
| ZA767379B (en) | 1977-11-30 |
| NL7613643A (nl) | 1977-06-15 |